CVE-2026-15415
MEDIUM
5.5
CVSS 3.1
Description
AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research.
Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input.
To remediate this issue, users should upgrade to version 0.0.36 or later.
Metadata
Severity & Metrics
5.5
MEDIUM CVSS 3.1
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N
Affected products (1)
| Vendor | Product | Platform | Versions |
|---|---|---|---|
| AWS | aws-healthomics-mcp-server | — | 0 < 0.0.36 |
Weakness (CWE)
| CWE | Source | Description |
|---|---|---|
| CWE-23 | cna | CWE-23 Relative path traversal |
CVSS scores (2)
| Score | Severity | Version | Source | Vector |
|---|---|---|---|---|
| 6.8 | MEDIUM | 4.0 | cna | CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N |
| 5.5 | MEDIUM | 3.1 | cna | CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N |
References (3)